Azra AI Appoints Oncology Expert Jessica Turgon to Board of Directors
Azra AI announced in a press release the appointment of oncology strategist Jessica Turgon to its Board of Directors. Turgon is a healthcare executive with decades of experience advising health systems, cancer centers, and healthcare organizations on oncology growth and operational transformation.
Before joining Azra AI, Turgon served as Global Service Line Head for Oncology at Siemens Healthineers and spent 20 years at ECG Management Consultants, where she led oncology consulting initiatives across the United States. Her work has focused on helping health systems modernize oncology operations and improve patient care delivery.
Azra AI develops an enterprise platform that uses advanced AI, multimodal data integration, and workflow automation to coordinate cancer care and clinical trial pathways. The platform supports health systems in patient identification, care coordination, research and clinical trial matching, and reporting. Deployed across hundreds of health systems, it aims to reduce time to treatment and improve patient outcomes and operational efficiency.
Turgon said she is joining the Board to help Azra AI expand its impact in helping health systems turn fragmented data into coordinated, actionable care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 McGraw Hill Adds AI Study Tools to Connect Oct 16 RapidCanvas Raises $29 Million to Expand Enterprise AI Platform Oct 16 Goodweek Raises $12 Million for AI Management Platform Oct 16 ALTOUR Unveils AI Platform for Corporate Travel Decisions Oct 16 BOC Group Adds AI Assistant to ADOIT 21More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Jarrard Expands AI Consulting Team
Astrin Names Medical Director as Certitude Breast Expands Nationwide
Teragonia Launches Astra Labs for Enterprise AI Workflows
PointClickCare Adds Former Appen CEO Armughan Ahmad to Board
Cognetryx Names Julia Cherashore to Advisory Board
Daily AI Brief: the AI news that matters, in your inbox.